Insulin grew into a big business as the number of cases of diabetes ballooned across the globe. Diabetes was the first disease that was termed a lifestyle disease. Obesity is the reverse. It is often a problem amongst the poor who cannot afford high-quality foods and end up eating a lot of ultra-processed foods.
A drug is offering hope and billing itself as a solution to the problem. Its popularity has soared and caused the company that manufactures it to be valued more than the country in which it resides. This is the story of Wegovy and Novo Nordisk.
You can also read the entire article here
Source of assets used - Intro Music
You can also follow the podcast on Apple Podcast, Spotify, Amazon Music, Audible, and Podbean
Philanthropy | Podcast
Techocalypse | Podcast
Taxing the Rich | Podcast
Accessibility - A Podcast with Thomas Logan
Crypto Policy | Podcast
Small Oil | Podcast
Carbon Markets | Podcast
Dark Patterns | Podcast
Learning by Proxy | Podcast | Insult to Injury
Learning by Proxy | Podcast | Dead Meat
Learning by Proxy | Podcast | Mutation Vs Mute Nation
Learning by Proxy | Podcast | Tracking Behaviour
Learning by Proxy | Podcast | Indecent Exposure
Learning by Proxy | Podcast | Chipping Away
Learning by Proxy | Podcast | Covid Returns
Learning by Proxy | Podcast | Fearing Innovation
Learning by Proxy | Podcast | NFT
Learning by Proxy | Podcast | Under-Currents
Co-Working in India | Podcast with Yatin Thakur
Learning by Proxy | Podcast | The name is Bond
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money